Conference Day 2

12:10 pm - 12:15 pm Chairman's Opening Remarks

12:15 pm - 12:50 pm Smith and Nephew’s Journey to UDI Compliance

Mark East - Global UDI Program Manager, Smith & Nephew


-      Discuss key challenges and practical solutions to achieving UDI compliance

-      Ask the question: What does the future hold for UDI

img

Mark East

Global UDI Program Manager
Smith & Nephew

12:50 pm - 1:30 pm Use of GS1 Standards for Successful UDI Implementation

Sylvia Reingardt - Senior Manager Healthcare, GS1


•Deep dive into UDI and GS1

•Uncover the role of GS1 as UDI issuing agency/entity

•Analyse UDI worldwide: challenge and opportunities

img

Sylvia Reingardt

Senior Manager Healthcare
GS1

1:30 pm - 1:50 pm Coffee Break

Deep dive into the advantages and disadvantages of using EUDAMED as a source of master data for healthcare providers, by hearing the perspectives of hospitals as well as medical device manufactures. Prepare for a fiery conversation! 

img

Dr. Hajo Reißmann

Former Head of Medical Supply Controlling
University Medical Center Schleswig Holstein

img

Myriam Dahani

Regulatory Affairs Manager
Novomed Group

img

John Wilkinson

Chair
Global Medical Devices Nomenclature Agency

2:40 pm - 3:15 pm Case Study: How to master the global UDI Challenge

Patrick Pfau - CEO & Co-Founder, projektraum36


-      Explore the challenges of achieving global UDI Compliance at Enterprise Scale

-      Discuss what strategic considerations need to be made before establishing a global UDI setup

-      Consider the relevance of an flexible and extensible framework capable of handling multiple agencies to achieve worldwide UDI compliance

-      Analyse the transition plan to establish an global UDI program on the example of current UDI projects for FDA GUDID and EC EUDAMED

-      Deep dive into the main phases of an UDI project and how the phases of multiple projects merge into an ongoing UDI program cycle to define your global UDI setup

img

Patrick Pfau

CEO & Co-Founder
projektraum36

3:15 pm - 3:50 pm UDI Requirements for the Vigilance Reporting Process

Dr. Fatima Sanfourche - Senior Manager RA/QA Compliance for Medical Devices and eHealth, Bayer
  • Explore major changes of vigilance systems due to the MDR requirements
  • Discuss how these regulations introduce an EU identification system for medical devices based on a Unique Device Identifier 
  • Consider the role of UDI in the traceability of the device during the vigilance reporting process 
  • Analyse the challenges of the implementation of the new electronic reporting process
  • Deep dive into how UDI will enhance the effectiveness of post-market safety-related activities for devices
img

Dr. Fatima Sanfourche

Senior Manager RA/QA Compliance for Medical Devices and eHealth
Bayer

3:50 pm - 4:00 pm Coffee Break

4:00 pm - 4:35 pm Live from the USA: FDA Perspective on UDI System Progress

Erin Quencer - Regulatory Health Scientist, FDA


- Explore updates to UDI implementation in the USA

- Delve into using AccessGUDID 

- Consider lessons learned 

img

Erin Quencer

Regulatory Health Scientist
FDA

-         Current status of US UDI implementation

-         Role and benefits of US UDI Collaborative Communities

-         Re-imagine Master Data Management

-               Applying innovation to scanning

-               Matching results to UDI-DI and data sources

-               Automating feedback to improve data quality

-         Health System Case Study 

img

Terrie Reed

Principal Consultant and Director Partner Relationships
Reed McCullough, LLC and Symmetric Health Solutions

img

Joseph D'Amore

Manager, Master Data Management
Boston Medical Center - Boston, MA

5:15 pm - 5:50 pm From Disaster to Demand Planning: UDI Delivers Value to Providers and Suppliers Today and Tomorrow

Karen Conway - Vice President, Healthcare Value, GHX


· Discuss how the pandemic is changing the nature of conversations between suppliers and providers, with greater focus on how to strengthen supply chain resiliency, enable demand planning and support bi-directional inventory visibility

· Examine how each of these outcomes can provide value across the entire supply chain, and have raised awareness of the value of UDIs beyond regulatory compliance

· Exploring how broader adoption of UDIs can support future pandemic and emergency response alongside how use of standard identifiers can help participants to increase efficiencies, lower costs, improve patient safety and support more strategic provider-supplier relationships.

img

Karen Conway

Vice President, Healthcare Value
GHX

5:40 pm - 5:50 pm Chairman's Closing Remarks